title: Controlled release of lysozyme from succinylated gelatin microspheres.
abstract: Gelatin was anionized to increase the carboxylic acid groups through succinylation. Succinylation of gelatin was performed using varying amounts of succinic anhydride. This gave various percentages of substitution. Lysozyme, a cationic antibacterial enzyme, which has important applications in the reduction of prosthetic valve endocarditis, was chosen as a model protein drug. Microspheres were prepared using unmodified gelatin and succinylated gelatin (SG) and lysozyme was incorporated into them. The percentage loading and release profiles of lysozyme for gelatin and SG microspheres were evaluated and compared. It was found that the SG microspheres exhibited higher loading efficiency for lysozyme (50%) than the unmodified gelatin microspheres. The in vitro release of lysozyme from SG microspheres occurred up to 122 h, compared to 96 h for gelatin microspheres, for the release of most of the lysozyme incorporated. This prolonged release of lysozyme from SG microspheres was attributed to the electrostatic interaction between the cationic lysozyme and the anionic SG microsphere carrier.
authors.affiliation: Biomaterials Division, Central Leather Research Institute, Chennai, India.
authors.forename: S S
authors.initials: SS
authors.lastname: Srinivas
authors.forename: K P
authors.initials: KP
authors.lastname: Rao
mesh_terms: D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005780:Gelatin / Q000737:chemistry; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D008863:Microspheres; D009113:Muramidase / Q000008:administration & dosage* / Q000737:chemistry; D010316:Particle Size; D055672:Static Electricity; D013386:Succinates / Q000737:chemistry
chemical_list: D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D013386:Succinates; C060085:succinylated gelatin; D005780:Gelatin; D009113:Muramidase